During different stages of tumorigenesis and metastasis, cancer cells evade apoptosis by modulating Bcl-2 protein family members, such as by the upregulation of antiapoptotic Bcl-2 proteins and the downregulation or removal of proapoptotic Bcl-2 members [221]. Here, BCL2 is linked to cancer.